SCHEMBL30324540

SCHEMBL30324540

Cn1cnc2nccc(Br)c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM2B Q8NHM5 1/20 0.33
▸ KDM4C Q9H3R0 1/20 0.33
▸ TRPA1 O75762 4/20 0.32
▸ DPP4 P27487 1/20 0.32
▸ GDA Q9Y2T3 2/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ NTSR1 P30989 1/20 0.32
▸ MC3R P41968 1/20 0.32
▸ NOTUM Q6P988 1/20 0.32
▸ SIRT3 Q9NTG7 1/20 0.32
▸ NR2E1 Q9Y466 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ TSHR P16473 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23089477 1.00 KDM2B (0.33) KDM2BKDM4CTRPA1DPP4GDA
SCHEMBL23107125 0.78 CCR1 (0.35) TRPA1DPP4GDAPIK3CDPOLB
SCHEMBL1702699 0.76 PRPS1 (0.39) KDM2BKDM4CTRPA1DPP4GDA
SCHEMBL19759411 0.73 ALOX15 (0.32) GDAPIK3CDPOLBADORA3CNR1
SCHEMBL25298063 0.72 TRPA1 (0.33) KDM2BKDM4CTRPA1ALDH1A1TSHR
SCHEMBL31028559 0.72 TRPA1 (0.33) KDM2BKDM4CTRPA1ALDH1A1TSHR
SCHEMBL3411236 0.71 ADORA2A (0.34) DPP4GDAPIK3CDPOLBADORA3
SCHEMBL31068648 0.71 HRH4 (0.41) GDAPIK3CDPOLBADORA3CNR1
SCHEMBL23104604 0.68 IRAK4 (0.33) —
SCHEMBL9981015 0.68 DPP4 (0.41) DPP4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12215105-B2 HPK1 antagonists and uses thereof Nimbus Saturn, Inc. (US) 2025-02-04 — — US disclosed
US-20240025898-A1 HPK1 ANTAGONISTS AND USES THEREOF SCHRÖDINGER, INC. 2024-01-25 — — US disclosed
US-11548890-B1 HPK1 antagonists and uses thereof Nimbus Saturn, Inc. (US) 2023-01-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11548890-B1 HPK1 antagonists and uses thereof PDXK, HIPK1, PCK1 KDM2B 3984/4885KDM4C 4066/4885TRPA1 4396/4885
US-20240025898-A1 HPK1 ANTAGONISTS AND USES THEREOF PDXK, HIPK1, PCK1 KDM2B 3984/4885KDM4C 4066/4885TRPA1 4396/4885
US-12215105-B2 HPK1 antagonists and uses thereof PDXK, HIPK1, PCK1 KDM2B 3984/4885KDM4C 4066/4885TRPA1 4396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback